⚙️
🌟 Najlepsze dopasowanie
Wpisz szukaną frazę, aby zobaczyć propozycje AI.

Deloitte reminds: “track every dose of the vaccine!”

Deloitte reminds: track every dose of the vaccine!

A new Deloitte report highlights the urgent need for the rapid adoption of a global barcode-based standard before the largest vaccine distribution campaign in history begins.

A recently published Deloitte report highlights the adoption of global standards in healthcare as an urgently needed solution to distribute COVID-19 vaccines quickly, efficiently, and safely. Tom Woods, Chair of the World Bank’s Global Steering Committee for Health Product Quality Assurance, calls for the adoption of common standards, including barcode scanning, as “the most critical and under-addressed element of protecting against vaccine distribution errors, enabling their tracking and safeguarding patients during COVID-19 vaccination campaigns.”
The authors of the Deloitte study Securing Trust in the Global COVID-19 Supply Chain point out that “the adoption of GS1 standards is another important element increasing trust at every stage of the supply chain, alongside cooperation and efficient communication among pharmaceutical industry representatives, and this trust ultimately impacts the patients themselves.”

Counterfeits won’t pass
GS1-compliant barcodes uniquely identify medical products, including vaccines, from the laboratory through clinical trials to the administration stage. By using GS1 standards, pharmaceutical manufacturers, distributors, and healthcare service providers follow protocols and safety measures, streamlining supply chain coordination and increasing its transparency. This reduces the risk of diversion, vaccine expiration, and the distribution of counterfeit copies. As a result, the public can be confident that both the vaccine itself and the process of bringing it to market are safe.
Although the degree of GS1 standard adoption in healthcare is constantly increasing, it is not yet a universal phenomenon. The Deloitte report emphasizes the importance of vaccine identification data (e.g., product identifier, batch number, and expiration date) as “essential” from the perspective of vaccination providers. The authors point to WHO recommendations “that all vaccines be labeled with standard barcodes.”

Global identification builds trust
Elżbieta Hałas, Member of the Board of GS1 Poland, emphasizes: – The world is facing a huge challenge related to the distribution and administration of vaccines. GS1 standards can ensure their reliable identification. Furthermore, they can help reduce the burden on healthcare workers and limit the risk of errors. Barcodes in healthcare have been saving the health and lives of patients for years. The effects of their use are already visible in Polish hospitals as well. Today, GS1 is ready to help all parties successfully carry out this critical operation.

In turn, Greg Reh, global leader of life sciences and healthcare at Deloitte, adds: – The level of transparency and public trust will be key to the acceptance of and confidence in COVID-19 vaccines, and adopting global standards from organizations like GS1 helps build trust in these vaccines.

Currently, over 70 countries use healthcare regulations and contractor requirements consistent with GS1 standards. These countries use two-dimensional (2D) GS1 DataMatrix barcodes, which allow for encoding information identifying the vaccine to reduce the risk of errors and ensure traceability.

More information can be found at: https://www.gs1.org/industries/healthcare/trust